L. Schwartz

Studies on desoxyribonuclease in systemic lupus erythematosus; non-participation of serum desoxyribonuclease in the L.E. phenomenon.

S. Lee, N. Kurnick, S. Pariser, 1952, The Journal of clinical investigation.

The use of adrenocorticotropic hormone and cortisone in the treatment of leukemia and leukosarcoma.

W. Dameshek, M. C. Rosenthal, L. Schwartz, 1951, Blood.

A specific inhibitor for human desoxyribonuclease and an inhibitor of the lupus erythematosus cell phenomenon from leucocytes.

S. Lee, N. Kurnick, S. Pariser, 1953, The Journal of clinical investigation.

The treatment of acquired hemolytic anemia with adrenocorticotrophic hormone (ACTH).

W. Dameshek, M. C. Rosenthal, L. Schwartz, 1951, The New England journal of medicine.

Association of antibody-coated red blood cells with ulcerative colitis; report of four cases.

L. Wasserman, M. Lorber, L. Schwartz, 1955, The American journal of medicine.

A SPECIFIC INHIBITOR FORHUMAN DESOXYRIBONUCLEASE ANDAN INHIBITOR OF THE LUPUSERYTHEMATOSUS CELL PHENOMENON FROMLEUCOCYTES

Stanley L. Lee, N. Kurnick, S. Pariser, 2013 .

The combined study of agglutination, hemolysis and erythrophagocytosis, with special reference to acquired hemolytic anemia.

L. Schwartz, J. A. Bonnin, 1954, Blood.

AOTH AND CORTISONE IN LEUKEMIA AND LEUKOSARCOMA 805 lymphocytic leukemia given single small doses of purified ACTH

W. Dameshek, C. Rosenthal, L. Schwartz, 2005 .

Blood coagulation and the L. E. cell phenomenon.

S. Lee, S. Pariser, L. Schwartz, 1954, Blood.

Reversible Agglutination of Trypsin Treated Erythrocytes by Normal Human Sera.∗

M. C. Rosenthal, L. Schwartz, 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.